Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Cancers|August 19, 2020
Prediction of Response and Survival Following Treatment with Azacitidine for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes after Allogeneic Hematopoietic Stem Cell TransplantationChristina Rautenberg, Anika Bergmann, Ulrich Germing, et al.
Cancers|December 23, 2022
Clinical and Cytogenetic Characterization of Early and Late Relapses in Patients Allografted for Myeloid Neoplasms with a Myelodysplastic ComponentVictoria Platte, Anika Bergmann, Barbara Hildebrandt, et al.
Blood Cancer Journal|November 13, 2019
EASIX for prediction of survival in lower-risk myelodysplastic syndromesAlmuth Merz, Ulrich Germing, Guido Kobbe, et al.
Transplantation and Cellular Therapy|October 13, 2025
Treosulfan-Based Conditioning Ameliorates the Impact of Pretransplantation Measurable Residual Disease-Positivity in Acute Myeloid Leukemia Patients Allografted in RemissionJacob Pyka, Judith Metzdorf, Christian Reicherts, et al.
Leukemia Research|May 14, 2021
Eligibility for clinical trials is unsatisfactory for patients with myelodysplastic syndromes, even at a tertiary referral centerKathrin Nachtkamp, Josefine Stark, Andrea Kündgen, et al.
JCO Clinical Cancer Informatics|January 13, 2022
Feasibility of Wearable-Based Remote Monitoring in Patients During Intensive Treatment for Aggressive Hematologic MalignanciesMalte Jacobsen, Pauline Rottmann, Till A Dembek, et al.
Annals of Hematology|November 16, 2020
Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study GroupEsther Schuler, Eva-Maria Wagner-Drouet, Salem Ajib, et al.
Leukemia|March 6, 2024
Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis: A retrospective analysis of the DRST and GREM registriesJohannes Lübke, Deborah Christen, Juliana Schwaab, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2017
Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating AgentsSophie Park, Jean-François Hamel, Andrea Toma, et al.
The Lancet. Haematology|January 29, 2021
Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort studyLisa Pleyer, Michael Leisch, Alexandra Kourakli, et al.
Pageof 2